“Can Vaginal Microbiota Act as a Biomarker for the Risk of Gynaecological Precancer and Cancer?”

Dear Editor, The female reproductive system hosts unique microbial communities that are crucial for maintaining women’s vaginal health and safeguarding the vaginal environment from numerous genitourinary infections [1,2]. The Vaginal Microbiota (VMB) interacts continuously with both the host and it...

Full description

Saved in:
Bibliographic Details
Main Authors: Bhagyashri Patil Takbhate, Swati Bhakare
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2024-12-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://www.jcdr.net/articles/PDF/20370/74427_CE[Ra1]_F(SHU)_QC(AN_IS)_PF1(RI_SHU)_PFA(KM)_PN(IS).pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846128987723530240
author Bhagyashri Patil Takbhate
Swati Bhakare
author_facet Bhagyashri Patil Takbhate
Swati Bhakare
author_sort Bhagyashri Patil Takbhate
collection DOAJ
description Dear Editor, The female reproductive system hosts unique microbial communities that are crucial for maintaining women’s vaginal health and safeguarding the vaginal environment from numerous genitourinary infections [1,2]. The Vaginal Microbiota (VMB) interacts continuously with both the host and its surroundings, forming a complex system. Recently, the correlation between microbiota and various health conditions has gained considerable attention. While the gastrointestinal microbiota has been the primary focus, research has increasingly explored other areas of the body, including the female genital tract. Dysbiosis in the female genital tract, marked by an imbalance in microbial communities, has been identified as a potential contributor to several gynaecological disorders, like endometriosis, inflammatory diseases of the pelvis, Polycystic Ovary Syndrome (PCOS) and gynaecological malignancies [1]. Disruption of the VMB can trigger inflammation and weaken immune defences, potentially creating conditions conducive to cancer development.
format Article
id doaj-art-b94bbf14d0ac4b1b816edfc82b424e4f
institution Kabale University
issn 2249-782X
0973-709X
language English
publishDate 2024-12-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj-art-b94bbf14d0ac4b1b816edfc82b424e4f2024-12-10T11:29:47ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2024-12-011812010210.7860/JCDR/2024/74427.20370“Can Vaginal Microbiota Act as a Biomarker for the Risk of Gynaecological Precancer and Cancer?”Bhagyashri Patil Takbhate0Swati Bhakare 1Research Fellow, Department of Central Research Facility, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Pimpri Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pune, Maharashtra, India.Senior Resident, Department of Obstetrics and Gynaecology, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Pimpri Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pune, Maharashtra, India.Dear Editor, The female reproductive system hosts unique microbial communities that are crucial for maintaining women’s vaginal health and safeguarding the vaginal environment from numerous genitourinary infections [1,2]. The Vaginal Microbiota (VMB) interacts continuously with both the host and its surroundings, forming a complex system. Recently, the correlation between microbiota and various health conditions has gained considerable attention. While the gastrointestinal microbiota has been the primary focus, research has increasingly explored other areas of the body, including the female genital tract. Dysbiosis in the female genital tract, marked by an imbalance in microbial communities, has been identified as a potential contributor to several gynaecological disorders, like endometriosis, inflammatory diseases of the pelvis, Polycystic Ovary Syndrome (PCOS) and gynaecological malignancies [1]. Disruption of the VMB can trigger inflammation and weaken immune defences, potentially creating conditions conducive to cancer development.https://www.jcdr.net/articles/PDF/20370/74427_CE[Ra1]_F(SHU)_QC(AN_IS)_PF1(RI_SHU)_PFA(KM)_PN(IS).pdfcervical cancerendometrial cancerlactobacilliovarian cancer
spellingShingle Bhagyashri Patil Takbhate
Swati Bhakare
“Can Vaginal Microbiota Act as a Biomarker for the Risk of Gynaecological Precancer and Cancer?”
Journal of Clinical and Diagnostic Research
cervical cancer
endometrial cancer
lactobacilli
ovarian cancer
title “Can Vaginal Microbiota Act as a Biomarker for the Risk of Gynaecological Precancer and Cancer?”
title_full “Can Vaginal Microbiota Act as a Biomarker for the Risk of Gynaecological Precancer and Cancer?”
title_fullStr “Can Vaginal Microbiota Act as a Biomarker for the Risk of Gynaecological Precancer and Cancer?”
title_full_unstemmed “Can Vaginal Microbiota Act as a Biomarker for the Risk of Gynaecological Precancer and Cancer?”
title_short “Can Vaginal Microbiota Act as a Biomarker for the Risk of Gynaecological Precancer and Cancer?”
title_sort can vaginal microbiota act as a biomarker for the risk of gynaecological precancer and cancer
topic cervical cancer
endometrial cancer
lactobacilli
ovarian cancer
url https://www.jcdr.net/articles/PDF/20370/74427_CE[Ra1]_F(SHU)_QC(AN_IS)_PF1(RI_SHU)_PFA(KM)_PN(IS).pdf
work_keys_str_mv AT bhagyashripatiltakbhate canvaginalmicrobiotaactasabiomarkerfortheriskofgynaecologicalprecancerandcancer
AT swatibhakare canvaginalmicrobiotaactasabiomarkerfortheriskofgynaecologicalprecancerandcancer